← All trials
NCT07076082
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 15, 2025
- Primary completion
- Oct 30, 2027
- Completion date
- Oct 30, 2028
- First posted
- Jul 21, 2025
- Last posted
- Oct 20, 2025
- Enrollment
- 350
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- The Spectrum Health GroupLead sponsor
- The Spectrum Health GroupSponsor investigator
- Henry Ford Health SystemCollaborator
- The Spectrum Health GroupOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.